Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Corsini

Showing results (161-170 of 200) with videos related to

Pageof 20
Sort By:
Cardiovascular Diabetology|August 24, 2023
Circulating PCSK9 as a prognostic biomarker of cardiovascular events in individuals with type 2 diabetes: evidence from a 16.8-year follow-up studyMassimiliano Ruscica, Chiara Macchi, Angelica Giuliani, et al.
European Journal of Preventive Cardiology|November 28, 2018
Long-term exposure to air pollution raises circulating levels of proprotein convertase subtilisin/kexin type 9 in obese individualsChiara Macchi, Nicola Ferri, Chiara Favero, et al.
Atherosclerosis Plus|July 3, 2026
LDL-cholesterol distance to target: A practical tool for guiding lipid-lowering treatment decisionsMaria Chiara Palloni, Teresa Farella, Andrea Faggiano, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 24, 2019
Differential effects of red yeast rice, Berberis aristata and Morus alba extracts on PCSK9 and LDL uptakeMaria G Lupo, Chiara Macchi, Silvia Marchianò, et al.
Bioorganic & Medicinal Chemistry|September 2, 2011
Synthesis, structural, and biological evaluation of bis-heteroarylmaleimides and bis-heterofused imidesNicola Ferri, Tiziano Radice, Manuela Antonino, et al.
Thrombosis and Haemostasis|April 17, 2015
Fibronectin extra domain A stabilises atherosclerotic plaques in apolipoprotein E and in LDL-receptor-deficient miceVivek Krishna Pulakazhi Venu, Patrizia Uboldi, Ashish Dhyani, et al.
Drug Safety|November 10, 2012
Current challenges and controversies in drug-induced liver injuryAlberto Corsini, Patricia Ganey, Cynthia Ju, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|June 1, 2018
Plasma PCSK9 levels and lipoprotein distribution are preserved in carriers of genetic HDL disordersMassimiliano Ruscica, Sara Simonelli, Margherita Botta, et al.
Journal of Clinical Medicine|December 24, 2021
HDL in COVID-19 Patients: Evidence from an Italian Cross-Sectional StudyBianca Papotti, Chiara Macchi, Chiara Favero, et al.
Frontiers in Cardiovascular Medicine|January 24, 2022
Associations Among PCSK9 Levels, Atherosclerosis-Derived Extracellular Vesicles, and Their miRNA Content in Adults With ObesityChiara Macchi, Maria Francesca Greco, Chiara Favero, et al.
Pageof 20

Showing results (161-170 of 200) with videos related to

Sort By:
Pageof 20
Cardiovascular Diabetology|August 24, 2023
Circulating PCSK9 as a prognostic biomarker of cardiovascular events in individuals with type 2 diabetes: evidence from a 16.8-year follow-up studyMassimiliano Ruscica, Chiara Macchi, Angelica Giuliani, et al.
European Journal of Preventive Cardiology|November 28, 2018
Long-term exposure to air pollution raises circulating levels of proprotein convertase subtilisin/kexin type 9 in obese individualsChiara Macchi, Nicola Ferri, Chiara Favero, et al.
Atherosclerosis Plus|July 3, 2026
LDL-cholesterol distance to target: A practical tool for guiding lipid-lowering treatment decisionsMaria Chiara Palloni, Teresa Farella, Andrea Faggiano, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 24, 2019
Differential effects of red yeast rice, Berberis aristata and Morus alba extracts on PCSK9 and LDL uptakeMaria G Lupo, Chiara Macchi, Silvia Marchianò, et al.
Bioorganic & Medicinal Chemistry|September 2, 2011
Synthesis, structural, and biological evaluation of bis-heteroarylmaleimides and bis-heterofused imidesNicola Ferri, Tiziano Radice, Manuela Antonino, et al.
Thrombosis and Haemostasis|April 17, 2015
Fibronectin extra domain A stabilises atherosclerotic plaques in apolipoprotein E and in LDL-receptor-deficient miceVivek Krishna Pulakazhi Venu, Patrizia Uboldi, Ashish Dhyani, et al.
Drug Safety|November 10, 2012
Current challenges and controversies in drug-induced liver injuryAlberto Corsini, Patricia Ganey, Cynthia Ju, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|June 1, 2018
Plasma PCSK9 levels and lipoprotein distribution are preserved in carriers of genetic HDL disordersMassimiliano Ruscica, Sara Simonelli, Margherita Botta, et al.
Journal of Clinical Medicine|December 24, 2021
HDL in COVID-19 Patients: Evidence from an Italian Cross-Sectional StudyBianca Papotti, Chiara Macchi, Chiara Favero, et al.
Frontiers in Cardiovascular Medicine|January 24, 2022
Associations Among PCSK9 Levels, Atherosclerosis-Derived Extracellular Vesicles, and Their miRNA Content in Adults With ObesityChiara Macchi, Maria Francesca Greco, Chiara Favero, et al.
Pageof 20